Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

Phillips 66 (PSX)

As of 2026-11-08 · 12/15 boxes filled from SEC filings and market data

Conclusion: SHORT

Conviction medium · base case -71% · downside -83% · upside 0%

PSX is a cyclical refiner/midstream with no durable moat: FY2022 net income to common was $11.01B, FY2024 was $2.11B, and the FY2020-FY2025 average is $3.64B (S24, S2), while TTM is $12.57B (N13). At today's 7.6x P/E (N25), the cycle average supports only about $27.7B of equity, or $70.9/share (-71.1% vs $245.72), and the FY2024 trough of $2.11B supports $41.1/share (-83.3%); only TTM or better earnings at the same multiple supports today's price (about 0%). The market is capitalizing the Q3 2026 refining spike - $38.00/bbl realized margin, 98% utilization, $6.031B refining pre-tax (S29, S31) - as if it were normalized, even though 1Q 2026 showed $207M of earnings and $(2,264)M operating cash flow (S104). I would short PSX: base -71.1%, downside -83.3%, upside about 0%, with the main risk being that TTM refining margins and buybacks persist.

Key numbers

  • Share price: $245.72
  • Market cap: $95.85B
  • Latest financial period: TTM to Sep 30, 2026
  • Revenue (TTM): $168.19B
  • P/E (TTM): 7.6x
  • Price / book: 2.79x

The 15 boxes

  1. ✓ 1. Long-form business notes

    Phillips 66 is a five-segment downstream and midstream company (FY2025 10-K: Midstream, Chemicals, Refining, Marketing and Specialties, Renewable Fuels), versus four segments in the FY2020 10-K before Renewable Fuels existed. Revenue is violently cyclical in the supplied data: $64.13B in FY2020, a $169.99B peak in FY2022, then -13% to $147.40B in FY2023 and $132.38B in FY2025, while net income to common swung from -$3.98B (FY2020) to $11.01B (FY2022) and $2.11B (FY2024) before recovering to $4.39B in FY2025. Operating cash flow over FY2020-FY2025 ran $2.11B to $10.81B, so the normalization base for a cyclical valuation is a wide range, not a point. Between the two 10-Ks the portfolio moved toward fee-based midstream (about 70,000 pipeline miles at Dec 31, 2025 versus over 22,000 at Dec 31, 2020) and away from refining (13 refineries in the FY2020 10-K versus 10 at Dec 31, 2025).

  2. ✓ 2. Competitive advantage

    The sources show no durable competitive advantage. The 10-K's own competition section describes commodity-style rivalry on cost, feedstock access, distribution and customer service, and states that Chemicals market position cannot necessarily be protected by product differentiation. The return record is cyclical, not durable: net income to common ran -$3.98B (FY2020), $11.01B (FY2022), $2.11B (FY2024) and $4.39B (FY2025), and operating cash flow fell from $10.81B (FY2022) to $4.96B (FY2025). The only quasi-moats disclosed are Midstream asset proximity/rates and a 583-patent portfolio the company says no segment depends on.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 was a refining-margin-led quarter: sales and other operating revenues rose 46% YoY, worldwide realized refining margin was $38.00/bbl, and reported/adjusted earnings were $5.6B with $7.3B operating cash flow. Cash was $5.8B at Sep 30 2026 and total debt fell to $18.5B; nine-month operating cash flow was $12.3B and shareholder returns $4.4B. Comparatives are distorted by Q3 2025's $948M WRB impairment and Jan 2025's $1B Coop gain, and the 10-Q reports no material risk-factor changes from the 2025 10-K.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ✓ 9. Insider trading interpretation

    Filled; members read this box.

  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans